Abstract
Objective
To investigate the association of psychiatric and cognitive comorbidities with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (TBI).
Methods
A total of 100 patients with persistent PTH attributed to mild TBI and 100 age- and gender-matched healthy controls free of mild TBI were enrolled between July 2018 and June 2019. Quality of sleep was evaluated using the Pittsburgh Sleep Quality Index, while symptoms of anxiety and depression were assessed using the Hospital Anxiety and Depression Scale. Cognitive impairment was evaluated using the Montreal Cognitive Assessment questionnaire, while post-traumatic stress disorder (PTSD) was assessed using the Harvard Trauma Questionnaire.
Results
In 100 patients with persistent PTH, 85% reported poor quality sleep, compared with 42% of healthy controls (P < 0.01). The relative frequency of probable to high risk of anxiety was 52% in the persistent PTH group vs. 8% in healthy controls (P < 0.01), while the relative frequency of probable to high risk of depression was 42% in the persistent PTH group vs. 2% in healthy controls (P < 0.01). Furthermore, 27% of the patients with persistent PTH had mild cognitive impairment while 10% had probable PTSD.
Conclusions
Poor quality of sleep as well as symptoms suggestive of anxiety and depression were more common in patients with persistent PTH than healthy controls. Clinicians should screen patients with persistent PTH for these comorbidities and develop treatment plans that account for their presence.
Keywords: Sleep, Anxiety, Depression, Cognitive impairment, Post-traumatic stress disorder
Introduction
Headache is a common sequela of mild traumatic brain injury (TBI), [1–3], as well as a frequent cause of chronic daily headache in the general population [4]. Few efforts have been made to assess the broader clinical picture of post-traumatic headache (PTH), [5–7]. The diagnosis of PTH is based on clinical criteria provided by the International Classification of Headache Disorders, 3rd edition (ICHD-3), and termed headache attributed to traumatic injury to the head [8]. Herein, PTH is characterized as either acute PTH, which develops within 7 days of the TBI and then remits within 3 months of onset, or persistent PTH, which persists beyond the 3 month-mark [8]. PTH is furthermore classified according to the severity of attributable TBI, being either mild or moderate to severe [8].
A key observation from clinic-based studies is that persistent PTH most often resembles a migraine-like headache phenotype, although some patients may report a ‘pure’ tension-type-like headache (TTH-like) phenotype [2, 5, 9]. Although the headache features of persistent PTH have been documented in multiple studies [2, 5, 6, 9], there is a scarcity of literature on associated comorbidities [7]. These include sleep disturbances, anxiety, depression, cognitive impairment, and post-traumatic stress disorder (PTSD) [7]. From a clinical standpoint, it is important to assess comorbidities as they are likely to have an important role in the long-term management and well-being of the patient. The presence of comorbidities might also affect the choice of therapy and, thus, facilitate more informed treatment approaches.
In this cross-sectional study, we assessed quality of sleep, anxiety, depression, cognitive impairment, and PTSD as comorbidities of persistent PTH. Age- and gender-matched healthy controls were used to compare rates of poor quality of sleep, anxiety, and depression. We hypothesized that symptoms suggestive of these comorbidities would be more frequent in patients with persistent PTH, compared with healthy controls.
Methods
Study population
We enrolled patients with persistent PTH attributed to mild TBI. Patients were recruited from the outpatient clinic of the Danish Headache Center, the Danish post-concussion syndrome support group website (hjernerystelsesforeningen.dk), and from neurological departments and rehabilitation centers in the Capital Region of Denmark. Healthy non-headache controls were recruited through the Danish research subject website (http://gsperson.dk) and posters placed at various public institutions in the Capital Region of Denmark. A trained locum doctor (HMA) was responsible for the initial screening of study eligibility by phone.
This article is part of a larger parental study that was approved by the Regional Health Research Ethics Committee of the Capital Region of Denmark (H-18011477), [5]. All participants gave written consent after receiving detailed oral and written information. The study was conducted at the Danish Headache Center in accordance with the Declaration of Helsinki [10], with later revisions. The study was also approved by the Danish Data Protection Agency.
Inclusion and exclusion criteria
The diagnosis of persistent PTH attributed to mild TBI was established by a trained locum doctor (AI) using a semi-structured interview and made in accordance with the ICHD-3 criteria for persistent headache attributed to mild traumatic injury to the head [8]. Table 1 sets out the ICHD-3 criteria for mild traumatic injury to the head. Other inclusion criteria for individuals with persistent PTH were: 1) mild TBI to have occurred at least 12 months prior to study participation and 2) age between 18 and 65 years. Exclusion criteria were 1) any history of primary headache disorder (except infrequent TTH), 2) any history of whiplash injury or more than one TBI, 3) pregnant or nursing women, 4) cardiovascular or cerebrovascular disease, 5) pre-trauma psychiatric disorder (unless well-regulated), and 6) medication-overuse headache. To ensure eligibility for inclusion, medical records were reviewed to cross-check for any formal medical or psychiatric diagnosis. Moreover, we required no intake of analgesics within 24 h of study participation because study participants were scheduled for functional magnetic resonance imaging and blood sampling as part of the larger parental study. Some of the data from the larger parental study have been published elsewhere [5, 11, 12].
Table 1.
Diagnostic criteria for mild traumatic injury to the head.a
| Mild traumatic injury to the head | |
|---|---|
| Injury to the head fulfilling both of the following: | |
| 1. Associated with none of the following: | |
| Loss of consciousness for > 30 min | |
| Glasgow Coma Scale (GCS) score < 13 | |
| Post-traumatic amnesia lasting > 24 h1 | |
| Altered level of awareness for > 24 h | |
| Imaging evidence of a traumatic head injury such as skull fracture, intracranial haemorrhage and/or brain contusion | |
| 2. Associated with one or more of the following symptoms and/or signs | |
| transient confusion, disorientation or impaired consciousness | |
| loss of memory for events immediately before or after the head injury | |
| two or more of the following symptoms suggestive of mild traumatic brain injury: | |
| nausea | |
| vomiting | |
| visual disturbances | |
| dizziness and/or vertigo | |
| gait and/or postural imbalance | |
| impaired memory and/or concentration |
aDiagnostic criteria are from the International Classification of Headache Disorders, 3rd edition (ICHD-3), [8]
Inclusion criteria for healthy controls were 1) age between 18 and 65 years, 2) no history of known head trauma or whiplash injury, 3) no history of primary headache disorder (except infrequent episodic TTH), 4) no first-degree relatives with primary headache disorder, 5) no daily intake of medicine other than oral contraceptives, 6) no history of neurological or psychological disorders, 7) no history of structural heart disease. An in-person structured interview was performed by a trained locum doctor (AI) to determine study eligibility. Medical records were reviewed to cross-check for any formal medical or psychiatric diagnosis.
Measures
An in-person semi-structured interview was used to record data on demographics, medical history, and full clinical course. The assignment of headache phenotypes was based on review of clinical features in patients with persistent PTH and without consideration of the ICHD-3 criterion for primary headache disorders, which states “not better accounted for by another ICHD-3 diagnosis”. As study inclusion was based on a diagnosis of persistent PTH attributed mild TBI, we used terms such as migraine-like and TTH-like to describe assigned headache phenotypes. The case definitions, that were used to classify migraine-like and TTH-like days, have been published elsewhere [13].
Pittsburg sleep quality index
The Pittsburg Sleep Quality Index (PSQ-I) is a 19-item self-report instrument that comprises 7 components used to assess quality of sleep [14]. Each component is scored on a scale of 0 to 3, which is then used to calculate a global score of 0 to 21. Poor quality of sleep is defined as global scores of 5 or higher. The appraisal period is the past 30 days.
Hospital anxiety and depression scale
The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report instrument used to screen for anxiety and depression separately [15]. The range of the scale is 0 to 21, with scores of 8 to 10 being indicative of a probable risk of anxiety or depression, whereas scores of 11 to 21 indicate a high risk of anxiety or depression. The appraisal period is the past 7 days.
Montreal cognitive assessment
The Montreal Cognitive Assessment (MoCA) questionnaire is a 30-item instrument used to screen for cognitive impairment [16]. The range of the scale is 0 to 30, and scores of 26 or less are indicative of cognitive impairment. The degree of cognitive impairment is denoted as mild if scores are between 18 to 25. The MoCA questionnaire was only administered to patients with persistent PTH.
Harvard trauma questionnaire
The Harvard Trauma Questionnaire (HTQ) is a 16-item instrument used to screen for PTSD [17]. Each item is rated on a four-point Likert scale, and total mean scores of 2.5 or higher are indicative of probable PTSD. The appraisal period is the past 7 days. The HTQ questionnaire was only administered to patients with persistent PTH.
Statistical analysis
Descriptive statistics were used to summarize baseline characteristics. Continuous variable were reported as means and standard deviations (SDs), whereas categorical variables were summarized as proportions and/or percentages. Comparisons were performed using a t test for continuous variables and a χ2 test for categorical variables. For analyses of correlation, we used the Spearman rank correlation coefficient (rs). All statistical analyses were conducted using IBM SPSS Statistics for Windows, Version 25.0, Armonk, NY, USA.
Results
A total of 100 patients with persistent PTH and 100 age- and gender-matched healthy controls were enrolled between July 2018 and June 2019. Of 100 participants in both groups, 83 were females and 17 were males. The mean age (SD) was 36.0 (11.6) years in patients with persistent PTH and 35.8 (11.3) years in healthy controls. Furthermore, the mean BMI (SD) was 24.5 (4.1) kg/m2 in patients with persistent PTH and 24.3 (3.7) kg/m2 in healthy controls. A more detailed summary has been published elsewhere [5] and is also presented in Tables 2, 3 and 4. In brief, patients with persistent PTH had a mean (SD) headache frequency of 25.4 (7.1) days per month. The most common headache phenotypes were chronic migraine-like (n = 61) followed by combined episodic migraine-like and episodic/chronic TTH-like (n = 29), ‘pure’ chronic TTH-like (n = 9), and episodic migraine-like headache (n = 1), (Table 3).
Table 2.
Summary Characteristics
| Variable | Persistent PTH (n = 100) | Healthy Controls (n = 100) |
|---|---|---|
| Age, mean (SD), y | 36.0 (11.7) | 35.8 (11.3) |
| Male/Female, % | 17/83 | 18/82 |
| Height, mean (SD), cm | 171.3 (8.2) | 170.9 (8.7) |
| Weight, mean (SD), kg | 72.1 (14.4) | 71.2 (14.2) |
| Body Mass Index, mean (SD), kg/m2 | 24.5 (4.1) | 24.3 (3.7) |
Table 3.
Characteristics of Patients with Persistent Post-Traumatic Headache
| Variable | Persistent PTH (n = 100) |
|---|---|
| Age, mean (SD), y | 36.0 (11.7) |
| Male/Female, % | 17/83 |
| Height, mean (SD), cm | 171.3 (8.2) |
| Weight, mean (SD), kg | 72.1 (14.4) |
| Body Mass Index, mean (SD), kg/m2 | 24.5 (4.1) |
| Current Employment Status, % | |
| Full-time employed | 37 |
| Part-time employed | 42 |
| Unemployed | 21 |
| Education | |
| Years of education, mean (SD), y | 15.6 (2.8) |
| No education besides completion of secondary school or high school, % | 17 |
| Skilled labor, % | 25 |
| Bachelor’s degree, % | 38 |
| Higher education, % | 20 |
| Injury Cause, % | |
| Fall | 42 |
| Motor vehicle collision | 18 |
| Sports-related injury | 8 |
| Violence/assault | 2 |
| Other unintentional injury | 30 |
| Localization of Mild TBI, % | |
| Frontal | 41 |
| Temporal | 27 |
| Parietal | 15 |
| Occipital | 27 |
| Mild TBI associated with, % | |
| Transient confusion, disorientation, or impaired consciousness | 82 |
| Loss of memory for events immediately before or after the head injury | 67 |
| Nausea | 82 |
| Vomiting | 24 |
| Visual disturbances | 46 |
| Dizziness and/or vertigo | 87 |
| Gait and/or postural imbalance | 53 |
| Impaired memory and/or concentration | 84 |
| Months with Headache attributed to Mild TBI, mean (SD), months | 49.3 (37.3) |
| Headache Phenotypes, % | |
| Chronic migraine-like | 61 |
| Episodic migraine-like | 1 |
| Episodic migraine-like combined with chronic TTH-like | 25 |
| Episodic migraine-like combined with frequent TTH-like | 2 |
| Episodic migraine-like combined with infrequent TTH-like | 2 |
| Chronic TTH-like | 9 |
| Self-Rated Health, % | |
| Excellent | 2 |
| Great | 12 |
| Good | 34 |
| Rather poor | 38 |
| Poor | 14 |
| Medico-Legal Issues / Litigation, % | |
| Ongoing litigation | 31 |
| Ended litigation | 44 |
| Improvement in headache following end of litigation, No. of subjects (%) | 1 (2.3%) |
| Pre-Trauma Psychiatric History, % | 23 |
| Anxiety disorders | 12 |
| Major depressive disorder | 14 |
| Eating disorders | 4 |
| Pre-Trauma Chronic Pain Conditionsa, % | 11 |
| Neck pain | 0 |
| Low back pain | 3 |
| Neuropathic pain | 1 |
| Other chronic pain conditions | 9 |
achronic pain was defined as persistent or recurrent pain that lasted longer than 3 months
Table 4.
Headache Characteristics of the Study Population
| Variable | Persistent PTH (n = 100) | Chronic Migraine-Like (n = 61) | Episodic Migraine-Like combined with TTH-like (n = 29) | Chronic TTH-like (n = 9) |
|---|---|---|---|---|
| Headache Frequency, mean (SD) | ||||
| Yearly headache days | 307.9 (86.9) | 299.3 (88.3) | 318.5 (83.0) | 358.1 (12.8) |
| Monthly headache days | 25.4 (7.1) | 24.6 (7.5) | 26.2 (6.8) | 29.7 (0.7) |
| Headache Intensitya, % | ||||
| Mild | 5 | 0 | 0 | 56 |
| Moderate | 80 | 82 | 86 | 44 |
| Severe | 15 | 18 | 14 | 0 |
| Headache Localization, % | ||||
| Bilateral | 64 | 69 | 62 | 56 |
| Unilateral | 36 | 31 | 38 | 44 |
| Left sided | 18 | 16 | 17 | 22 |
| Right sided | 17 | 15 | 21 | 22 |
| Frontal | 70 | 70 | 72 | 67 |
| Temporal | 50 | 51 | 41 | 67 |
| Parietal | 35 | 39 | 21 | 44 |
| Occipital | 35 | 41 | 24 | 33 |
| Headache Quality, % | ||||
| Throbbing | 18 | 23 | 14 | 0 |
| Pressing | 32 | 21 | 31 | 100 |
| Stabbing | 3 | 2 | 7 | 0 |
| Combined (throbbing and pressing) | 45 | 51 | 48 | 0 |
| Other headache quality | 2 | 3 | 0 | 0 |
| Family History of Primary Headache Disordersb, % | 28 | 31 | 21 | 22 |
| Continuous Photophobiac, % | 46 | 69 | 45 | 44 |
| Continuous Phonophobiad, % | 60 | 61 | 28 | 0 |
| Neck Pain, % | 78 | 82 | 79 | 44 |
| > 180 days with neck pain within the past 12 months, % | 55 | 78 | 52 | 33 |
| Low Back Pain, % | 37 | 38 | 45 | 11 |
| > 180 days with neck pain within the past 12 months, % | 24 | 26 | 23 | 0 |
| Allodyniae | ||||
| None, % | 54 | 44 | 66 | 78 |
| Mild Allodynia, % | 23 | 25 | 21 | 22 |
| Moderate Allodynia, % | 17 | 23 | 10 | 0 |
| Severe Allodynia, % | 6 | 8 | 3 | 0 |
amild headache intensity = does not impair ability to work and/or other activities. Moderate headache intensity = impairs but does not prevent ability to work and/or other activities. Severe headache intensity = prevents ability to work and/or other activities
bpositive family history of primary headache disorders = 1st degree relative with any primary headache disorder other than infrequent tension-type headache
ccontinuous photophobia = continuously ongoing – daily – symptoms of photophobia
dcontinuous phonophobia = continuously ongoing – daily – symptoms of phonophobia
ecutaneous allodynia scores were assessed using the 12-item Allodynia Symptom Checklist (ASC-12) and defined as follows: none (scores 0–2), mild [3–5], moderate [6–8], and severe (≥9)
Associated comorbidities
Tables 5 and 6 summarize outcome rates for poor quality of sleep, anxiety, depression, mild cognitive impairment, and PTSD. In 100 patients with persistent PTH, 85% had poor quality of sleep, 52% had at least probable risk of anxiety, 42% had at least probable risk of depression, 27% had mild cognitive impairment, and 10% had probable PTSD. Compared with healthy controls, patients with persistent PTH had a higher relative frequency of poor quality of sleep (85% vs. 42%, P < 0.01), anxiety (52% vs. 8%, P < 0.01), and depression (42% vs. 2%, P < 0.01). Another observation was that 28% of patients with persistent PTH had poor quality of sleep, as well as at least probable risk of both anxiety and depression.
Table 5.
Comorbidities of the Study Population
| Comorbidities | Persistent PTH (n = 100) | Healthy Controls (n = 100) | P value |
|---|---|---|---|
| Subjective Sleep Quality | |||
| Poor Sleep Qualitya, No. | 85 | 42 | < 0.01 |
| Anxiety | < 0.01 | ||
| Probable or High Risk of Anxiety, No. | 52 | 8 | |
| Probable Risk of Anxiety, % | 19 | 8 | |
| High Risk of Anxiety, % | 33 | 0 | |
| Depression | < 0.01 | ||
| Probable or High Risk of Depression, No. | 42 | 2 | |
| Probable Risk of Depression, % | 30 | 2 | |
| High Risk of Depression, % | 12 | 0 | |
| Mild Cognitive Impairment, No. | 27 | N/A | N/A |
| Post-Traumatic Stress Disorder, No. | 10 | N/A | N/A |
Table 6.
Comorbidities of the Chronic Migraine-Like Group
| Comorbidities | Chronic Migraine-Like (n = 61) |
Other Headache Phenotypes (n = 39) | P value |
|---|---|---|---|
| Subjective Sleep Quality | |||
| Poor Sleep Quality, % | 93 | 72 | < 0.05 |
| Anxiety | |||
| Probable or High Risk of Anxiety, % | 46 | 54 | 0.35 |
| Depression | |||
| Probable or High Risk of Depression, % | 56 | 74 | 0.32 |
In 91 patients with a migraine-like phenotype, 88% had poor quality of sleep, 56% had at least probable risk of anxiety, and 43% had at least probable risk of depression. The corresponding figures for 61 patients with a chronic migraine-like phenotype were 93%, 46%, and 56% (Table 6).
Correlations
Global PSQ-I scores correlated with HADS anxiety scores (r = 0.31; P < 0.01) and HADS depression scores (r = 0.37; P < 0.01), whereas no significant correlation was found with monthly headache days (r = 0.19; P = 0.18), monthly migraine-like days (r = 0.19; P = 0.08), or months with headache attributed to mild TBI (r = 0.08; P = 0.42). HADS anxiety scores correlated with HADS depression scores (r = 0.56; P < 0.01), whilst no relationship was observed with monthly headache days (r = − 0.02; P = 0.86), monthly migraine days (r = 0.02; P = 0.83), or months with headache attributed to mild TBI (r = − 0.13; P = 0.19). HADS depression scores did not correlate with monthly headache days (r = 0.02; P = 0.84), monthly migraine days (r = 0.15; P = 0.15), or months with headache attributed to mild TBI (r = − 12; P = 0.23).
Discussion
This study presents data on comorbidities in 100 patients with persistent PTH and 100 age- and gender-matched healthy controls. When comparing the two groups, poor quality of sleep (85% vs. 42%), at least probable risk of anxiety (52% vs. 8%), and at least probable risk of depression (42% vs. 2%) were more frequently observed in patients with persistent PTH. In addition, mild cognitive impairment was present in 27% of patients with persistent PTH, whilst probable PTSD was found in 10%. These findings underscore that patients with persistent PTH often experience symptoms suggestive of psychiatric and cognitive comorbidities. An initial screening for comorbid conditions should be used in clinical practice to facilitate treatment schemes that are more carefully matched to patients. This, in turn, would be a much needed move away from the conventional one-size-fits-all approach.
Our finding of poor quality of sleep in most patients with persistent PTH is in accord with previous observations [7, 18]. A recent clinic-based study found that 26% of patients with persistent PTH had a severe degree of insomnia, whilst 40% had a moderate degree of insomnia [18]. The same study also found that insomnia was more frequent in patients with persistent PTH, compared with patients with migraine [18]. This is an interesting observation because a recent web-based survey reported that insomnia is more common in individuals with migraine than non-migraine controls [19]. A meta-analysis has estimated that sleep disturbances are experienced by about 50% of individuals who sustain a TBI [20], Taken together, it is evident that poor quality of sleep is prevalent in patients with persistent PTH attributed to mild TBI.
Besides poor quality of sleep, we found that anxiety and depression are more frequent in patients with persistent PTH, compared with healthy controls. These associations have several possible explanations. For example, anxiety and depression may be independent risk factors for the development of TBI-related sequelae, such as persistent PTH. Another option is that anxiety and depression are sequelae of TBI that are unrelated to persistent PTH per se. Lastly, they could indeed be linked to persistent PTH. Many studies indicate that that anxiety and depression are common sequela in patients with TBI [21, 22]. A prospective cohort study found that the relative frequency of anxiety and depression was higher in patients with persistent PTH, compared with those who had sustained a mild TBI but did not report headache [23]. Longitudinal data is required to resolve the timing of PTH, anxiety, depression following mild TBI.
An interesting finding from our study is that mild cognitive impairment was experienced by 27% of patients with persistent PTH. This is in line with findings from a prospective cohort study of patients with mild TBI [24]. The authors reported that about 60% of patients, who had sustained a mild TBI, reported at least one cognitive symptom at 6 months and 12 months post-trauma [24]. Furthermore, another study found that cognitive performance at 2 weeks post-injury was lower in patients with mild TBI when compared with healthy controls [25].
Although there are robust data that the risk of PTSD is increased after mild TBI [22, 26, 27], it remains unclear to what extent individuals with persistent PTH are affected by PTSD. Two small clinic-based studies have found that about 30% of patients with persistent PTH have PTSD [28, 29]. In contrast, we found that 10% of patients with persistent PTH had probable PTSD. The discordant findings could be due to differences in methodology or the pre-injury characteristics of the study populations. Nonetheless, it should be noted that some experimental data does support a possible bidirectional relation between PTH and PTSD, possibly attributed to dysfunction in pain modulatory circuits [30].
Limitations
Several limitations should be noted before considering the implications of our findings. First, we excluded individuals with a personal history of primary headache disorder (except infrequent episodic TTH) from inclusion in the control group [8]. This might have affected the observed relative frequencies of poor quality of sleep, anxiety, and depression. Indeed, there is evidence to suggest an association of migraine and TTH with these comorbidities [19, 31–33]. Another point, that merits emphasis, is the occurrence of pre-trauma psychiatric history in 23% of patient with persistent PTH, compared with none in the control group. This might yield higher comorbidity scores for patients with persistent PTH. However, it should be mentioned that none of the patients with persistent PTH received treatment for any psychiatric disorder at the time of the mild TBI. Second, we used questionnaires for screening of comorbidities rather than diagnostic instruments. This could result in an over- or underestimation of the caseness prevalence. In addition, we are not able to provide a detailed clinical description of the assessed comorbidities when using screeners. Third, we used a cross-sectional design, which therefore does not allow for causality to be inferred. This study should, therefore, be considered a first step in the investigation of comorbidities associated with persistent PTH. Causation should be ascertained in future prospective cohort studies. Lastly, we recruited patients with persistent PTH who had sought medical care or were involved with patient-support groups. Thus, it is plausible that our study population is skewed towards more adversely affected individuals with persistent PTH.
Conclusions
Poor quality of sleep, anxiety, and depression are more common in patients with persistent PTH, compared with healthy controls. In addition, some patients with persistent PTH have symptoms suggestive of mild cognitive impairment and PTSD. These findings underscore that patients should be screened for common comorbidities during the initial clinical assessment. Recognition of these might, in turn, affect choice of therapy and highlight the need for more active follow-up. In addition, effective management of comorbidities might be useful in improving treatment outcomes for persistent PTH.
Acknowledgements
Not applicable.
Abbreviations
- TBI
Traumatic brain injury
- PTH
Post-traumatic headache
- ICHD-3
International Classification of Headache Disorders, Third Edition
- TTH-like
Tension-type headache-like
- PTSD
Post-traumatic stress disorder
- PSQ-I
Pittsburg Sleep Quality Index
- HADS
Hospital Anxiety and Depression Scale
- MoCA
Montreal Cognitive Assessment
- HTQ
Harvard Trauma Questionnaire
Authors’ contributions
HA: Study concept and design, acquisition of data, analysis (including statistical analyses) and interpretation, drafting the manuscript. HMA: Acquisition of data and critical revision of the manuscript for important intellectual content. AI: Acquisition of data and critical revision of the manuscript for important intellectual content. SA: Analysis (including statistical analyses) and interpretation, critical revision of the manuscript for important intellectual content. FMA: Critical revision of the manuscript for important intellectual content. RBL: Critical revision of the manuscript for important intellectual content. HWS: Study concept and design, critical revision of the manuscript for important intellectual content, supervision.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this Article: The study was supported by a research grant from Rigshospitalet Research Foundation (F-23340-02) as well as a research grant from the American Brain Foundation, American Academy of Neurology and the International Headache Society.
Availability of data and materials
Qualified researchers can request access to patient-level data and related study documents, including the study protocol. Patient-level data will be deidentified and study documents will be redacted to protect the privacy of study participants.
Declarations
Ethics approval and consent to participate
Informed written consent was obtained from each patient before conducting any study-related procedures. The study protocol was approved by the relevant ethics committee and institutional review board.
Consent for publication
Not applicable.
Competing interests
The authors declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: Sait Ashina has received honoraria from Allergan and Teva and consultant fees from Amgen and Allergan. Sait Ashina received honoraria for consulting for Allergan, Amgen, Eli Lilly, Novartis, Promius, Satsuma, Supernus, and Theranica. Faisal Mohammad Amin is a lecturer or scientific advisor for Teva, Eli Lilly, Lundbeck, and Novartis. Messoud Ashina has received personal fees from Alder BioPharmaceuticals, Allergan, Amgen, Eli Lilly, Novartis, and Teva. MA also participated in clinical trials as the principal investigator for Alder, Amgen, electroCore, Novartis, and Teva. Richard B. Lipton serves on the editorial boards of Neurology and Cephalalgia and as senior advisor to Headache; has received research support from the National Institutes of Health (NIH); receives support from the Migraine Research Foundation and the National Headache Foundation; has reviewed for the National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS); serves as consultant, advisory board member, or has received honoraria from Alder, Allergan, Amgen, Autonomic Technologies, Avanir, Boston Scientific, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeuraTherapeutics, GlaxoSmithKline, Merck, Novartis, Teva, and Vedanta; receives royalties from Wolff’s Headache and Informa; holds stock options in eNeura Therapeutics and Biohaven. Henrik Winther Schytz received speaking fees from Novartis and Teva. The other authors declare no conflicts of interest.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA. 2008;300(6):711–719. doi: 10.1001/jama.300.6.711. [DOI] [PubMed] [Google Scholar]
- 2.Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW, Dodick DW. Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol. 2019;15(10):607–617. doi: 10.1038/s41582-019-0243-8. [DOI] [PubMed] [Google Scholar]
- 3.Ashina H, Eigenbrodt AK, Seifert T, Sinclair AJ, Scher AI, Schytz HW, Lee MJ, de Icco R, Finkel AG, Ashina M. Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment. Lancet Neurol. 2021;20(6):460–469. doi: 10.1016/S1474-4422(21)00094-6. [DOI] [PubMed] [Google Scholar]
- 4.Couch JR, Lipton RB, Stewart WF, Scher AI. Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology. 2007;69(11):1169–1177. doi: 10.1212/01.wnl.0000276985.07981.0a. [DOI] [PubMed] [Google Scholar]
- 5.Ashina H, Iljazi A, Al-Khazali HM, Ashina S, Jensen RH, Amin FM, et al. Persistent post-traumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns. Cephalalgia. 2020;40(6):554–564. doi: 10.1177/0333102420909865. [DOI] [PubMed] [Google Scholar]
- 6.Lieba-Samal D, Platzer P, Seidel S, Klaschterka P, Knopf A, Wober C. Characteristics of acute posttraumatic headache following mild head injury. Cephalalgia. 2011;31(16):1618–1626. doi: 10.1177/0333102411428954. [DOI] [PubMed] [Google Scholar]
- 7.Minen MT, Boubour A, Walia H, Barr W. Post-concussive syndrome: a focus on post-traumatic headache and related cognitive, psychiatric, and sleep issues. Curr Neurol Neurosci Rep. 2016;16(11):100. doi: 10.1007/s11910-016-0697-7. [DOI] [PubMed] [Google Scholar]
- 8.Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi: 10.1177/0333102417738202. [DOI] [PubMed] [Google Scholar]
- 9.Theeler B, Lucas S, Riechers RG, 2nd, Ruff RL. Post-traumatic headaches in civilians and military personnel: a comparative, clinical review. Headache. 2013;53(6):881–900. doi: 10.1111/head.12123. [DOI] [PubMed] [Google Scholar]
- 10.World Medical A World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi: 10.1001/jama.2013.281053. [DOI] [PubMed] [Google Scholar]
- 11.Ashina H, Al-Khazali HM, Iljazi A, Ashina S, Jorgensen NR, Amin FM, et al. Low plasma levels of calcitonin gene-related peptide in persistent post-traumatic headache attributed to mild traumatic brain injury. Cephalalgia. 2020;40(12):1276–1282. doi: 10.1177/0333102420941115. [DOI] [PubMed] [Google Scholar]
- 12.Ashina H, Iljazi A, Al-Khazali HM, Christensen CE, Amin FM, Ashina M, et al. Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache. Ann Neurol. 2020;88(6):1220–1228. doi: 10.1002/ana.25915. [DOI] [PubMed] [Google Scholar]
- 13.Ashina H, Iljazi A, Amin FM, Ashina M, Lipton RB, Schytz HW. Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study. J Headache Pain. 2020;21(1):134. doi: 10.1186/s10194-020-01202-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
- 15.Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1(1):29. doi: 10.1186/1477-7525-1-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi: 10.1111/j.1532-5415.2005.53221.x. [DOI] [PubMed] [Google Scholar]
- 17.Mollica RF, Caspi-Yavin Y, Bollini P, Truong T, Tor S, Lavelle J. The Harvard trauma questionnaire. Validating a cross-cultural instrument for measuring torture, trauma, and posttraumatic stress disorder in Indochinese refugees. J Nerv Ment Dis. 1992;180(2):111–116. doi: 10.1097/00005053-199202000-00008. [DOI] [PubMed] [Google Scholar]
- 18.Kim SK, Chong CD, Dumkrieger G, Ross K, Berisha V, Schwedt TJ. Clinical correlates of insomnia in patients with persistent post-traumatic headache compared with migraine. J Headache Pain. 2020;21(1):33. doi: 10.1186/s10194-020-01103-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. doi: 10.1186/s10194-020-1084-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mathias JL, Alvaro PK. Prevalence of sleep disturbances, disorders, and problems following traumatic brain injury: a meta-analysis. Sleep Med. 2012;13(7):898–905. doi: 10.1016/j.sleep.2012.04.006. [DOI] [PubMed] [Google Scholar]
- 21.Scholten AC, Haagsma JA, Cnossen MC, Olff M, van Beeck EF, Polinder S. Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury: a systematic review. J Neurotrauma. 2016;33(22):1969–1994. doi: 10.1089/neu.2015.4252. [DOI] [PubMed] [Google Scholar]
- 22.Stein MB, Jain S, Giacino JT, Levin H, Dikmen S, Nelson LD, Vassar MJ, Okonkwo DO, Diaz-Arrastia R, Robertson CS, Mukherjee P, McCrea M, Mac Donald CL, Yue JK, Yuh E, Sun X, Campbell-Sills L, Temkin N, Manley GT, and the TRACK-TBI Investigators. Adeoye O, Badjatia N, Boase K, Bodien Y, Bullock MR, Chesnut R, Corrigan JD, Crawford K, Diaz-Arrastia R, Dikmen S, Duhaime AC, Ellenbogen R, Feeser VR, Ferguson A, Foreman B, Gardner R, Gaudette E, Giacino JT, Gonzalez L, Gopinath S, Gullapalli R, Hemphill JC, Hotz G, Jain S, Korley F, Kramer J, Kreitzer N, Levin H, Lindsell C, Machamer J, Madden C, Martin A, McAllister T, McCrea M, Merchant R, Mukherjee P, Nelson LD, Noel F, Okonkwo DO, Palacios E, Perl D, Puccio A, Rabinowitz M, Robertson CS, Rosand J, Sander A, Satris G, Schnyer D, Seabury S, Sherer M, Stein MB, Taylor S, Toga A, Temkin N, Valadka A, Vassar MJ, Vespa P, Wang K, Yue JK, Yuh E, Zafonte R. Risk of posttraumatic stress disorder and major depression in civilian patients after mild traumatic brain injury: a TRACK-TBI study. JAMA Psychiatry. 2019;76(3):249–258. doi: 10.1001/jamapsychiatry.2018.4288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yilmaz T, Roks G, de Koning M, Scheenen M, van der Horn H, Plas G, Hageman G, Schoonman G, Spikman J, van der Naalt J. Risk factors and outcomes associated with post-traumatic headache after mild traumatic brain injury. Emerg Med J. 2017;34(12):800–805. doi: 10.1136/emermed-2015-205429. [DOI] [PubMed] [Google Scholar]
- 24.McMahon P, Hricik A, Yue JK, Puccio AM, Inoue T, Lingsma HF, et al. Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study. J Neurotrauma. 2014;31(1):26–33. doi: 10.1089/neu.2013.2984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Frenette LC, Tinawi S, Correa JA, Alturki AY, LeBlanc J, Feyz M et al (2018) Early detection of cognitive impairments with the Montreal cognitive assessment in patients with uncomplicated and complicated mild traumatic brain injury. Brain Inj:1–9 [DOI] [PubMed]
- 26.Iljazi A, Ashina H, Al-Khazali HM, Lipton RB, Ashina M, Schytz HW, et al. Post-traumatic stress disorder after traumatic brain injury-a systematic review and meta-analysis. Neurol Sci. 2020;41(10):2737–2746. doi: 10.1007/s10072-020-04458-7. [DOI] [PubMed] [Google Scholar]
- 27.Iljazi A, Ashina H, Al-Khazali HM, Ashina M, Schytz HW, Ashina S. Post-traumatic stress disorder attributed to traumatic brain injury in children - a systematic review. Brain Inj. 2020;34(7):857–863. doi: 10.1080/02699052.2020.1764104. [DOI] [PubMed] [Google Scholar]
- 28.Kjeldgaard D, Forchhammer H, Teasdale T, Jensen RH. Chronic post-traumatic headache after mild head injury: a descriptive study. Cephalalgia. 2014;34(3):191–200. doi: 10.1177/0333102413505236. [DOI] [PubMed] [Google Scholar]
- 29.Chibnall JT, Duckro PN. Post-traumatic stress disorder in chronic post-traumatic headache patients. Headache. 1994;34(6):357–361. doi: 10.1111/j.1526-4610.1994.hed3406357.x. [DOI] [PubMed] [Google Scholar]
- 30.Defrin R, Riabinin M, Feingold Y, Schreiber S, Pick CG. Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism. J Neurotrauma. 2015;32(1):28–37. doi: 10.1089/neu.2014.3359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol. 2010;1:16. doi: 10.3389/fneur.2010.00142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Ozge A, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485–1495. doi: 10.1016/S0140-6736(20)32160-7. [DOI] [PubMed] [Google Scholar]
- 33.Ashina S, Mitsikostas DD, Lee MJ, Yamani N, Wang SJ, Messina R, Ashina H, Buse DC, Pozo-Rosich P, Jensen RH, Diener HC, Lipton RB. Tension-type headache. Nat Rev Dis Primers. 2021;7(1):24. doi: 10.1038/s41572-021-00257-2. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Qualified researchers can request access to patient-level data and related study documents, including the study protocol. Patient-level data will be deidentified and study documents will be redacted to protect the privacy of study participants.